SII CEO urges US to lift raw material export ban to up vaccine production

Adar Poonawalla on Friday said the US needs to lift its embargo on raw material exports

Press Trust of India Mumbai
Adar Poonawalla, CEO, Serum Institute

Adar Poonawalla, CEO, Serum Institute

Serum Institute of India (SII) CEO Adar Poonawalla on Friday said the US needs to lift its embargo on raw material exports to help ramp up vaccine production.

SII is currently manufacturing anti-coronavirus vaccine Covishield, developed by Astrazeneca and Oxford University. The vaccine is not only being used in India, but exported to a number of countries.

Poonawalla had earlier admitted that SII has been facing problems in sending out required number of batches of vaccines due to the bureaucratic and government-related hurdles.

Tagging the twitter handle of the President of the United States, Poonawalla said in a tweet, "Respected @POTUS, if we are to truly unite in beating this virus, on behalf of the vaccine industry outside the U.S., I humbly request you to lift the embargo of raw material exports out of the U.S. so that vaccine production can ramp up. Your administration has the details.

Also Read

Ahead of Covid-19 vaccine rollout, second mock drill across India on Jan 8

UK begins AstraZeneca Covid-19 vaccine rollout with dialysis patient

French coronavirus vaccine rollout slowed by focus on elderly, red tape

Acceleration in vaccine rollout achieved with help of private sector: Govt

Oil prices fall 2% as inventories rise and vaccine rollout stalls

China's GDP hits record growth but post-Covid recovery seen losing steam

Covid: PM Modi reviews medical oxygen situation in 12 high burden states

Karnataka CM Yediyurappa tests Covid positive for second time in 8 months

United Kingdom finds 77 cases of Covid variant first found in India

No state has asked to stop train services: Railway Board chairman

First Published: Apr 16 2021 | 3:28 PM IST

Explore News